HEALTHY CHOICE WELLNESS CORP

Insider Trading & Executive Data

HCWC
NYSEARCA
Consumer Defensive
Packaged Foods

Start Free Trial

Get the full insider signal for HCWC

6 insider trades in the last year. Go beyond summary counts with transaction-level detail, compensation intelligence, and institutional ownership context.

Trade-level insider transactions with filing links, transaction codes, and footnotes
Executive compensation trends by role with year-over-year comparisons
Institutional ownership shifts by quarter with top-holder concentration data
Form 144 and Form 8-K monitoring with AI analysis and CSV export tools

Insider Activity Summary

Insider Trades (1Y)
6
0 in last 30 days
Buy / Sell (1Y)
6/0
Acquisitions / Dispositions
Unique Insiders (1Y)
6
Active in past year
Insider Positions
7
Current holdings
Position Status
7/0
Active / Exited
Institutional Holders
34
Latest quarter
Board Members
0

Compensation & Governance

Avg Total Compensation
N/A
Historical average
Executives Covered
0
Comp records available
Form 8-K Events (1Y)
0
Personnel Changes (1Y)
0
Bonus Plan Events (1Y)
0
Organization Changes (1Y)
0
Board Appointments (1Y)
0
Board Departures (1Y)
0

Restricted Sales

Form 144 Filings (1Y)
0
Form 144 Insiders (1Y)
0
Planned Sale Shares (1Y)
0
Planned Sale Value (1Y)
$0.00
Price
$0.30
Market Cap
$5.7M
Volume
2,912
EPS
$-0.09
Revenue
$19.0M
Employees
450
About HEALTHY CHOICE WELLNESS CORP

Company Overview

Healthy Choice Wellness Corp. (HCWC) operates a portfolio of community-oriented natural and organic grocery and wellness retail banners plus an e-commerce/wholesale channel (TheVitaminStore.com), running ~19 stores across several states and carrying roughly 10,000 SKUs from ~1,000 suppliers. Recent growth has been acquisition-driven (Ellwood Thompson’s full-year and GreenAcres Market in July 2024), producing revenue growth (2024 sales $69.4M, +24.6%) while the company remains loss-making but improving (net loss $4.5M in 2024 vs. $9.9M in 2023; adjusted EBITDA near breakeven in 2024 and positive in 2025 YTD). Key operational characteristics: store-level P&L responsibility, emphasis on USDA organic and supplement/regulatory compliance, material vendor concentration, modest headcount (~450), and tight liquidity with a $7.5M high‑interest loan, committed Series A preferred financing, and going‑concern disclosure.

Executive Compensation Practices

Given HCWC’s retail/packaged‑foods model and current financial profile, pay is likely tied to short‑term operating metrics (same‑store sales, gross margin, adjusted EBITDA, and store‑level P&L) and transaction milestones (successful integrations of acquisitions and cost‑out targets). Because the company is cash‑constrained and pursuing capital raises, management compensation probably relies more on equity and long‑term incentive awards (stock, options, or preferred equity participation) and milestone/earn‑out style grants rather than large cash bonuses; retention awards for integration teams are also likely. Variable pay frameworks will need to reflect regulatory and quality metrics (organic certification, supplier cGMP compliance) because failures can trigger reputational loss and impairment charges that materially affect results. Investors should expect lower base cash payouts, higher upside via equity, and possible special grants tied to capital‑raising, store rationalization, or achievement of positive adjusted EBITDA and liquidity milestones.

Insider Trading Considerations

Because HCWC is in a turnaround phase with active acquisitions, tight liquidity, and recent financings, insider trading activity may cluster around material events: acquisition announcements, financings (Series A, loans, IPO-related proceeds), quarterly results that show movement to profitability, and disclosure of cash‑runway or going‑concern developments. Expect insiders to use equity compensation for pay and potentially to seek liquidity through open‑market sales or private placements once lock‑ups/Series A restrictions expire; conversely, related‑party capital and insider participation in financings may show up as non‑market purchases. Regulatory constraints include Section 16 reporting (Form 3/4/5) and typical blackout periods around earnings and financing announcements; financing agreements and preferred stock terms may also impose contractual trading restrictions or transfer limits. Watch for 10b5‑1 trading plans, clustered sales around financings, and transactions that coincide with disclosures about supplier concentration, cash balances above FDIC limits, or lease/interest‑rate cost changes — all of which can materially move the stock.

Unlock Full Insider Trading Data
Get complete access to insider trades, executive compensation, institutional holdings, and AI-powered analysis for HEALTHY CHOICE WELLNESS CORP and thousands of other companies.
Individual insider trade details with transaction history
Executive compensation breakdown by position
Institutional holder analysis with quarterly comparisons
Insider holdings with temporal change tracking
Form 144 restricted sale filings with details
Form 8-K governance events and personnel changes
10b5-1 trading plan analysis
AI-powered insights and conversational analysis
Board of directors profiles and governance data
Advanced filtering, sorting, and CSV export
No credit card required
Cancel anytime